Wednesday, March 05, 2025 | 03:32 AM ISTहिंदी में पढें
Cipla Roche
Cipla will use Covid-19 bulk drugs inventory when demand rises
The Covid-19 portfolio contributed 5-6 per cent of Cipla's turnover during peak Covid waves, the firm said
 "Cipla will use Covid-19 bulk drugs inventory when demand rises")
Updated On : 11 May 2022 | 11:46 PM IST
Cipla launches Roche's Covid antibody cocktail in India for Rs 60k per dose
The antibody cocktail (Casirivimab and Imdevimab) is to be administered for the treatment of mild to moderate Covid-19 in adults and pediatric patients
 "Cipla launches Roche's Covid antibody cocktail in India for Rs 60k per dose")
Updated On : 24 May 2021 | 11:42 PM IST
Roche Pharma India expands partnership with Cipla for oncology medicines
The two companies had previously entered into a similar agreement in February 2018 for promotion and distribution of tocilizumab (Actemra) and other products
 "Roche Pharma India expands partnership with Cipla for oncology medicines")
Updated On : 18 Jun 2020 | 1:41 PM IST
Cipla, Roche turn partners for the first time to sell cancer drugs
Cipla and Roche settled patent dispute last year. Cipla withdrew its petition in Supreme Court against in the matter
 "Cipla, Roche turn partners for the first time to sell cancer drugs")
Updated On : 27 Feb 2018 | 9:09 PM IST
